Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Laura A. Kalayjian, MD

    TitleAssistant Professor of Clinical Neurology
    SchoolKeck School of Medicine of USC
    DepartmentNeurology
    AddressHCC 3rd Floor Room 3000
    Health Sciences Campus
    Los Angeles California 90089-9405
    Phone+1 323 442 5710
    vCardDownload vCard
      Other Positions
      TitleNeurology Chief, LAC+USC Medical Center

      TitleDirector, Neurophysiology Lab, LAC+USC Medical Center


      Collapse Overview 
      Collapse Overview
      Dr. Laura Kalayjian is Chief of Neurology and Director of the EEG Lab at LAC+USC Medical Center. She completed medical school at the University of Massachusetts in Worcester, MA and completed her neurology residency at Stanford University, Palo Alto, CA. She was fellowship trained in epilepsy and neurophysiology under Dr. Martha Morrell at Columbia Presbyterian, New York. She accepted a position at USC in July 2000. She has been active as co-director of the comprehensive epilepsy program and continues to pursue her research interests in women with epilepsy, hormonal influences and pregnancy and quality of life issues in persons with epilepsy.


      Collapse Biography 
      Collapse Awards and Honors
      Pasadena Magazine 2011Top Doctor

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lee B, Zubair MN, Marquez YD, Lee DM, Kalayjian L, Heck CN, Liu CY. A Single-Center Experience with the NeuroPace RNS System: A Review of Techniques and Potential Problems. World Neurosurg. 2015 Sep; 84(3):719-26. PMID: 25940211.
        View in: PubMed
      2. Kalayjian L. Valproate and pregnancy: think again. Neurology. 2015 Jan 27; 84(4):e25-6. PMID: 25628438.
        View in: PubMed
      3. Fu KA, DiNorcia J, Sher L, Velani SA, Akhtar S, Kalayjian L, Sanossian N. Predictive factors of neurological complications and one-month mortality after liver transplantation. Front Neurol. 2014; 5:275. PMID: 25566180; PMCID: PMC4269112.
      4. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014 Aug; 168(8):729-36. PMID: 24934501; PMCID: PMC4122685.
      5. Cohen MJ, Meador KJ, Browning N, May R, Baker GA, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav. 2013 Nov; 29(2):308-15. PMID: 24012508; PMCID: PMC3902100.
      6. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar; 12(3):244-52. PMID: 23352199; PMCID: PMC3684942.
      7. Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian L, Liporace JD, Privitera M, Crawford T, Loring DW, Meador KJ. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav. 2012 Aug; 24(4):449-56. PMID: 22749607; PMCID: PMC3483041.
      8. Herzog AG, Fowler KM, Smithson SD, Kalayjian L, Heck CN, Sperling MR, Liporace JD, Harden CL, Dworetzky BA, Pennell PB, Massaro JM. Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial. Neurology. 2012 Jun 12; 78(24):1959-66. PMID: 22649214; PMCID: PMC3369508.
      9. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012 Apr 17; 78(16):1207-14. PMID: 22491865; PMCID: PMC3324322.
      10. Cohen MJ, Meador KJ, Browning N, Baker GA, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav. 2011 Oct; 22(2):240-6. PMID: 21783425; PMCID: PMC3185140.
      11. Herzog AG, Fowler KM, Sperling MR, Liporace JD, Kalayjian L, Heck CN, Krauss GL, Dworetzky BA, Pennell PB. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia. 2011 Oct; 52(10):1843-8. PMID: 21756250; PMCID: PMC4572701.
      12. Herzog AG, Smithson SD, Fowler KM, Krishnamurthy KB, Sundstrom D, Kalayjian L, Heck CN, Oviedo S, Correl-Leyva G, Garcia E, Gleason KA, Dworetzky BA. Premenstrual dysphoric disorder in women with epilepsy: relationships to potential epileptic, antiepileptic drug, and reproductive endocrine factors. Epilepsy Behav. 2011 Aug; 21(4):391-6. PMID: 21724471.
        View in: PubMed
      13. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Cohen MJ, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav. 2011 Jun; 21(2):147-52. PMID: 21546316; PMCID: PMC3114203.
      14. Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011 Feb; 134(Pt 2):396-404. PMID: 21224309; PMCID: PMC3030767.
      15. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010 Nov 30; 75(22):1954-60. PMID: 21106960; PMCID: PMC3014232.
      16. Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, Liporace JD, Sam M, Kalayjian L, Thurman DJ, Moore E, Loring DW. Antiepileptic drug use in women of childbearing age. Epilepsy Behav. 2009 Jul; 15(3):339-43. PMID: 19410654; PMCID: PMC2741411.
      17. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16; 360(16):1597-605. PMID: 19369666; PMCID: PMC2737185.
      18. Meador KJ, Baker GA, Finnell RH, Kalayjian L, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006 Aug 08; 67(3):407-12. PMID: 16894099; PMCID: PMC1986655.
      19. Morrell MJ, Flynn KL, Doñe S, Flaster E, Kalayjian L, Pack AM. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav. 2005 May; 6(3):360-5. PMID: 15820344.
        View in: PubMed